Company: AGIO
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001439222-25-000089
Chunk: 111

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-07-31
Form: 10-Q
Item: Part II, Item 6
Chunk 111
---
 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing.

58

Table of Contents    

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 AGIOS PHARMACEUTICALS, INC.July 31, 2025By:/s/ Brian GoffBrian GoffChief Executive Officer(principal executive officer)July 31, 2025By:/s/ Cecilia JonesCecilia JonesChief Financial Officer(principal financial officer)

59